Atomera Incorporated (ATOM) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ATOM SEC filings page.
Atomera Incorporated (ATOM) reported $65K in revenue for fiscal year 2025, down 51.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Atomera's revenue remains tiny beside sustained research spending, so operations are financed mainly through external capital rather than sales.
Revenue fell from$550K in FY2023 to$65K in FY2025 while research spending stayed near$12M , revealing a development program whose cost is largely independent of commercial volume. The business therefore has not yet reached a scale where sales meaningfully absorb its operating base.
FY2025 reported liquidity equaled 15.5 months of annual operating outflow, alongside a 9.8x current ratio; this indicates substantial short-term asset coverage relative to obligations, not internally funded operations. Financing cash flow of
The FY2025 net loss was
Financial Health Signals
Atomera Incorporated does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Atomera Incorporated scores 17.31, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($161.2M) relative to total liabilities ($2.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Atomera Incorporated passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Atomera Incorporated reported a net loss of $20.2M while operations used $14.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Atomera Incorporated reported an operating loss of $21.1M against $60K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Atomera Incorporated generated $158K in revenue in Q2 2026. Against the prior quarter it is up 1336.4%.
Atomera Incorporated's EBITDA was -$6.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 28.8% from the same quarter a year earlier. Against the prior quarter it is down 6.9%.
Atomera Incorporated reported -$6.3M in net income in Q2 2026. This represents a decrease of 27.6% from the same quarter a year earlier. Against the prior quarter it is down 4.3%.
Atomera Incorporated earned -$0.17 per diluted share (EPS) in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Cash & Balance Sheet
Atomera Incorporated recorded an outflow of $3.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 11.3% from the same quarter a year earlier. Against the prior quarter it is up 15.1%.
Atomera Incorporated held $15.1M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Atomera Incorporated's gross margin was 83.5% in Q2 2026, indicating the percentage of revenue retained after direct costs.
Atomera Incorporated's ROE was -17.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 6.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.1 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Atomera Incorporated invested $3.3M in research and development in Q2 2026. This represents an increase of 9.4% from the same quarter a year earlier. Against the prior quarter it is down 4.9%.
Atomera Incorporated invested $16K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 60.0% from the same quarter a year earlier.
Not reported for Q2 2026.
ATOM Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $158K | $11K+175.0% | N/A | $11K-50.0% | $0-100.0% | $4K-77.8% | $23K | $22K |
| Cost of Revenue | $26K-58.1% | $126K | N/A | $128K+4166.7% | $62K-16.2% | $0-100.0% | $13K | $3K |
| Gross Profit | $132K+312.9% | -$115K-2975.0% | N/A | -$117K-715.8% | -$62K-3000.0% | $4K+126.7% | $10K | $19K |
| R&D Expenses | $3.3M+9.4% | $3.5M+6.2% | N/A | $3.3M+19.8% | $3.0M+16.0% | $3.3M+13.9% | $2.8M | $2.8M-16.5% |
| SG&A Expenses | $3.2M+54.6% | $2.3M+11.7% | N/A | $2.2M+19.5% | $2.0M+11.8% | $2.1M+15.3% | $1.8M | $1.8M+7.7% |
| Operating Income | -$6.8M-28.6% | -$6.3M-15.8% | N/A | -$5.8M-20.7% | -$5.3M-13.5% | -$5.5M-8.5% | -$4.9M | -$4.8M+10.3% |
| EBITDA | -$6.8M-28.8% | -$6.3M-15.9% | N/A | -$5.8M-20.8% | -$5.2M-13.6% | -$5.5M-8.7% | -$4.9M | -$4.8M+10.2% |
| Interest Expense | $1K-94.4% | $4K-81.0% | N/A | $12K-60.0% | $18K-48.6% | $21K-46.2% | $25K | $30K-36.2% |
| Net Income | -$6.3M-27.6% | -$6.1M-16.6% | N/A | -$5.6M-21.3% | -$5.0M-13.9% | -$5.2M-8.0% | -$4.7M | -$4.6M+8.8% |
| EPS (Basic) | -$0.170.0% | -$0.170.0% | -$0.14+12.5% | -$0.170.0% | -$0.17-6.3% | -$0.17+10.5% | -$0.16+11.1% | -$0.17+15.0% |
| EPS (Diluted) | -$0.170.0% | -$0.170.0% | -$0.14+12.5% | -$0.170.0% | -$0.17-6.3% | -$0.17+10.5% | -$0.16+11.1% | -$0.17+15.0% |
| Diluted Shares (Avg) | 39M+27.1% | 35M+16.6% | N/A | 31M+13.6% | 30M+14.8% | 30M+16.1% | N/A | 27M+8.5% |
Not reported in any period shown, so not listed: Income Tax.
ATOM Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $40.2M+67.0% | $43.6M+66.2% | $21.1M-27.6% | $21.9M+8.9% | $24.1M+10.1% | $26.3M+14.5% | $29.1M+21.2% | $20.1M-18.9% |
| Current Assets | $39.0M+71.2% | $42.1M+71.4% | $19.6M-27.6% | $21.0M+18.3% | $22.7M+20.1% | $24.5M+24.8% | $27.1M+32.8% | $17.8M-14.6% |
| Cash & Equivalents | $15.1M-31.2% | $14.2M-41.3% | $19.2M-25.5% | $20.3M+47.7% | $22.0M+52.1% | $24.1M+62.9% | $25.8M+104.7% | $13.8M+8.8% |
| Short-Term Investments | $23.2M | $26.9M | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $995K-85.7% | $3.6M-53.7% |
| Accounts Receivable | N/A | $41K | $0-100.0% | $137K+2183.3% | $0-100.0% | $0 | $6K | $6K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3.1M+12.7% | $3.1M+3.4% | $2.7M-33.0% | $2.9M-31.5% | $2.8M-36.4% | $3.0M-34.4% | $4.0M-30.9% | $4.2M-90.4% |
| Current Liabilities | $2.3M-18.1% | $2.2M-23.8% | $2.0M-44.1% | $2.9M-14.0% | $2.8M-11.2% | $2.9M-1.6% | $3.6M-6.2% | $3.4M+14.7% |
| Non-Current Liabilities | $860K | $896K+692.9% | $712K+51.2% | $0-100.0% | $0-100.0% | $113K-93.0% | $471K-77.0% | $861K-97.9% |
| Total Equity | $37.1M+74.1% | $40.5M+74.2% | $18.4M-26.7% | $19.0M+19.7% | $21.3M+21.8% | $23.3M+26.5% | $25.1M+38.0% | $15.9M+181.7% |
| Retained Earnings | -$254.1M-9.7% | -$247.8M-9.3% | -$241.7M-9.1% | -$237.3M-9.4% | -$231.7M-9.2% | -$226.7M-9.1% | -$221.5M-9.1% | -$216.9M-9.2% |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
ATOM Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.9M-11.2% | -$4.6M+3.7% | -$3.2M-6.4% | -$3.4M-16.1% | -$3.5M-10.8% | -$4.8M-15.3% | -$3.0M-4.1% | -$2.9M+16.7% |
| Depreciation & Amortization | $6K-50.0% | $9K-25.0% | $13K+8.3% | $11K-8.3% | $12K-7.7% | $12K-29.4% | $12K-29.4% | $12K-40.0% |
| Stock-Based Compensation | $1.7M+36.2% | $1.4M+39.3% | N/A | $1.3M+48.0% | $1.3M+29.5% | $1.0M-1.5% | N/A | $907K-12.9% |
| Capital Expenditures | $16K+60.0% | $0-100.0% | $22K+175.0% | $13K | $10K+66.7% | $4K | $8K | $0-100.0% |
| Free Cash Flow | -$3.9M-11.3% | -$4.6M+3.7% | -$3.2M-6.9% | -$3.4M-16.6% | -$3.5M-10.9% | -$4.8M-15.4% | -$3.0M-4.4% | -$2.9M+17.0% |
| Investing Cash Flow | $3.9M+38840.0% | -$27.0M-2809.6% | -$22K-100.8% | -$13K-104.8% | -$10K-101.5% | $996K-60.5% | $2.6M+198.1% | $272K-91.6% |
| Financing Cash Flow | $1.0M-28.8% | $26.5M+1145.7% | $2.1M-82.9% | $1.7M-11.9% | $1.4M-34.3% | $2.1M-44.5% | $12.4M+527.7% | $1.9M+6420.0% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
ATOM Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 83.5% | -1045.5% | N/A | -1063.6% | N/A | 100.0%+183.3pp | 43.5% | 86.4% |
| Operating Margin | -4277.9% | -57490.9% | N/A | -52663.6% | N/A | -136575.0% | -21182.6% | -21818.2% |
| Net Margin | -4010.1% | -55209.1% | N/A | -50663.6% | N/A | -130225.0% | -20247.8% | -20886.4% |
| Return on Equity | -17.1%+6.2pp | -15.0%+7.4pp | N/A | -29.3%-0.4pp | -23.3%+1.6pp | -22.4%+3.8pp | -18.6% | -28.9% |
| Return on Assets | -15.8%+4.9pp | -13.9%+5.9pp | N/A | -25.4%-2.6pp | -20.6%-0.7pp | -19.8%+1.2pp | -16.0% | -22.8%-2.5pp |
| Current Ratio | 17.02+8.9x | 19.34+10.7x | 9.80+2.2x | 7.23+2.0x | 8.14+2.1x | 8.59+1.8x | 7.58+2.2x | 5.25-1.8x |
| Debt-to-Equity | 0.080.0x | 0.08-0.1x | 0.150.0x | 0.15-0.1x | 0.13-0.1x | 0.13-0.1x | 0.16-0.2x | 0.27 |
| Asset Turnover | 0.000.0x | 0.000.0x | N/A | 0.000.0x | 0.000.0x | 0.000.0x | 0.00 | 0.000.0x |
| FCF Margin | -2476.6% | -41881.8% | N/A | -30681.8% | N/A | -119650.0% | -13200.0% | -13159.1% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Atomera Incorporated ATOM | FY2025 | $65K | -$20.2M | N/A | $161.2M | — |
| inTEST Corporation INTT | FY2025 | $113.8M | -$2.5M | -2.2% | $187.8M | 50/100 |
| Amtech Systems Inc ASYS | FY2025 | $79.4M | -$30.3M | -38.2% | $308.1M | 53/100 |
| AXT Inc AXTI | FY2025 | $88.3M | -$21.3M | -24.1% | $5.2B | 45/100 |
| Ichor Holdings ICHR | FY2025 | $947.7M | -$52.8M | -5.6% | $2.3B | 49/100 |
| SmartKem, Inc. SMTK | FY2025 | $697K | -$10.5M | N/A | $1.2M | — |
Where Atomera Incorporated Ranks
Frequently Asked Questions
What is Atomera Incorporated's annual revenue?
Atomera Incorporated (ATOM) reported $65K in total revenue for fiscal year 2025. This represents a -51.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Atomera Incorporated's revenue growing?
Atomera Incorporated (ATOM) revenue declined by 51.9% year-over-year, from $135K to $65K in fiscal year 2025.
Is Atomera Incorporated profitable?
No, Atomera Incorporated (ATOM) reported a net income of -$20.2M in fiscal year 2025.
What is Atomera Incorporated's EBITDA?
Atomera Incorporated (ATOM) had EBITDA of -$21.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Atomera Incorporated's return on equity (ROE)?
Atomera Incorporated (ATOM) has a return on equity of -109.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Atomera Incorporated's free cash flow?
Atomera Incorporated (ATOM) recorded an outflow of $14.9M in free cash flow during fiscal year 2025. This represents a -12.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Atomera Incorporated's operating cash flow?
Atomera Incorporated (ATOM) recorded an outflow of $14.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Atomera Incorporated's total assets?
Atomera Incorporated (ATOM) had $21.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Atomera Incorporated's capital expenditures?
Atomera Incorporated (ATOM) invested $49K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Atomera Incorporated spend on research and development?
Atomera Incorporated (ATOM) invested $12.3M in research and development during fiscal year 2025.
What is Atomera Incorporated's current ratio?
Atomera Incorporated (ATOM) had a current ratio of 9.80 as of fiscal year 2025, which is generally considered healthy.
What is Atomera Incorporated's debt-to-equity ratio?
Atomera Incorporated (ATOM) had a debt-to-equity ratio of 0.15 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Atomera Incorporated's return on assets (ROA)?
Atomera Incorporated (ATOM) had a return on assets of -95.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Atomera Incorporated's P/E ratio?
Atomera Incorporated (ATOM) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $161.2M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Atomera Incorporated's price-to-sales ratio?
Atomera Incorporated (ATOM) has no price-to-sales ratio at the moment: outside the range published as a multiple (on $65K revenue, FY2025). The market capitalization is $161.2M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Atomera Incorporated's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Atomera Incorporated (ATOM) held $19.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $14.9M over that year. Dividing the one by the other, the reported balance equals about 16 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Atomera Incorporated's Altman Z-Score?
Atomera Incorporated (ATOM) has an Altman Z-Score of 17.31, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Atomera Incorporated's Piotroski F-Score?
Atomera Incorporated (ATOM) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Atomera Incorporated's earnings high quality?
Atomera Incorporated (ATOM) reported a net loss of $20.2M while operations used $14.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Atomera Incorporated cover its interest payments?
Atomera Incorporated (ATOM) reported an operating loss of $21.1M against $60K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.